Why the study?
Data were limited regarding the association between hs-cTnT levels and STE-defined left ventricular systolic dysfunction in septic patients.
Does high-sensitivity cardiac troponin T (hs-cTnT) level predict subclinical left ventricular systolic dysfunction in patients with sepsis?
Does high-sensitivity cardiac troponin T (hs-cTnT) level predict subclinical left ventricular systolic dysfunction in patients with sepsis?
Serum hs-cTnT level is a useful biomarker for detecting subclinical left ventricular systolic dysfunction in patients with sepsis.
Answers are grounded in this paper and cite their sources.
May flag STE-detected LVSD in sepsis; leaves open whether troponin monitoring alters outcomes.
Background. Left ventricular systolic dysfunction (LVSD) is common in sepsis. Speckle-tracking echocardiography (STE) is a useful emerging tool for evaluating the intrinsic left ventricular systolic function. High-sensitivity cardiac troponin T (hs-cTnT) is the most sensitive biomarker of myocardial injury. However, there are limited data regarding the association between hs-cTnT level and left ventricular systolic dysfunction based on STE in septic patients. We performed this prospective study to evaluate the diagnostic value of hs-cTnT level for subclinical left ventricular systolic dysfunction measured by STE in septic patients according to the sepsis-3 definition. Methods. Patients with sepsis based on sepsis-3 definition admitted to the intensive care unit were prospectively performed STE and hs-cTnT level within 24 hours after the onset of sepsis. Baseline clinical and echocardiographic variables were collected. Left ventricular systolic dysfunction was defined as a global longitudinal strain of ≥−15%. Results. During a 19-month period, 116 patients were enrolled in the study. The elevated hs-cTnT level was seen in 86.2% of septic patients, and 43.1% of patients had LVSD on STE. The median hs-cTnT level and the proportion of elevated hs-cTnT level (>14 ng/L) were significantly higher in patients with LVSD than in patients without LVSD. The area under the ROC curves of hs-cTnT to detect LVSD was 0.73 ( <a:math xmlns:a="http://www.w3.org/1998/Math/MathML" id="M1"> <a:mi>P</a:mi> </a:math> < 0.001). In the multivariate analysis, hs-cTnT (HR, 1.002; 95% CI, 1.000 to 1.004; <c:math xmlns:c="http://www.w3.org/1998/Math/MathML" id="M2"> <c:mi>P</c:mi> </c:math> = 0.025) and septic shock (HR, 7.6; 95% CI, 2.25 to 25.76; <e:math xmlns:e="http://www.w3.org/1998/Math/MathML" id="M3"> <e:mi>P</e:mi> </e:math> = 0.001) were independent predictors of LVSD. Conclusion. Our study indicated that the serum hs-cTnT level might be a useful biomarker for detecting LVSD in septic patients.
No takes yet. Share an insight, caveat, or question.
Hai et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: